Exagen Inc. XGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $32.42M+45.8% | $22.24M-39.4% | $36.69M-41.4% | $62.59M-37.1% | ||
| $10.86M+38.5% | $7.84M+18.7% | $6.6M+8.2% | $6.1M-37.1% | ||
| $48.89M+34.1% | $36.46M-23.8% | $47.84M-34.1% | $72.61M-35.6% | ||
| $6.94M+31.3% | $5.28M+1.6% | $5.2M-36.5% | $8.2M+71.8% | ||
| $193K-30.1% | $276K-8.0% | $300K-17.1% | $362K— | ||
| $58.02M+29.8% | $44.69M-21.5% | $56.94M-34.0% | $86.22M-30.2% | ||
| $4.15M+0.4% | $4.14M+32.1% | $3.13M+2.8% | $3.05M+22.2% | ||
| $675K-7.9% | $733K— | —— | —— | ||
| $643K+52.0% | $423K+60.2% | $264K+38.9% | $190K— | ||
| $14.16M+4.8% | $13.51M+13.5% | $11.9M+23.7% | $9.62M+3.3% | ||
| $22.26M+12.3% | $19.82M+3.1% | $19.23M-33.2% | $28.78M+4.7% | ||
| $40.57M+15.4% | $35.15M+2.6% | $34.25M-21.7% | $43.76M+13.6% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$314.28M-6.8% | -$294.33M-5.4% | -$279.22M-9.3% | -$255.53M-22.8% | ||
| $17.45M+82.9% | $9.54M-58.0% | $22.69M-46.6% | $42.46M-50.0% | ||
| $58.02M+29.8% | $44.69M-21.5% | $56.94M-34.0% | $86.22M-30.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Exagen Inc.'s total assets?
- Exagen Inc. (XGN) holds $52.0M in total assets, up 28.9% year over year.
- How much debt does Exagen Inc. have?
- Exagen Inc. carries $27.1M in total debt against $14.4M of shareholders' equity, a debt-to-equity ratio of 1.88.
- How much cash does Exagen Inc. have?
- Exagen Inc. holds $21.7M in cash and equivalents.
- Can Exagen Inc. cover its short-term obligations?
- Its current ratio is 3.47 — current assets exceed current liabilities.
- Where does Exagen Inc.'s balance sheet data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
